Note : Some of our products which are under Patents in some Countries and Areas are only use for R&D, or sale to none Patents Countries and Areas.
CPHI China 2009, Shanghai
We will attend CPHI China 2009, Shanghai Date: 23-25 June 2009, Booth No.: E2N08 Welcome to visit us!
CPHI India 2008, Mumbai
We will attend CPHI India 2008, Mumbai , Date: 28-30 November 2008, Booth No.: CP15 Welcome to visit us!
API China 2008, Suzhou
We will attend API China 2008, Suzhou, Date: 5-7 November 2008, Booth No.: 4B111 Welcome to visit us!
 
Mubritinib
366017-09-6 Specification: 99%
Mubritinib Under Developing
 
Neratinib
CAS: 698387-09-6 Specification: 99%
Neratinib Under Developing
 
Pelitinib
CAS: 257933-82-7 Specification: 99%
Pelitinib Under Developing
 
Tandutinib
CAS: 387867-13-2 Spefication: 99%
Tandutinib DMF open part
 
Masitinib
CAS: 790299-79-5 Specification: 99%
Masitinib Under Developing
 
Dovitinib
CAS: 405169-16-6, 915769-50-5 Specification: 99%
Dovitinib Under Developing
 
Canertinib
CAS: 289499-45-2 Specification: 99%
Canertinib Under Developing
 
Axitinib
CAS: 319460-85-0 Specification: 99%
Axitinib Under Developing
 
Bosutinib
CAS: 380843-75-4 Specification: 99%
Bosutinib Under Developing
 
 
Add : Rm. 1706 Manley Commercial Building, 367-375 Queen’s Road Central H.K.
Fax : 0086-21-36162076
Tel : 0086-21-36162072, 61175616
Email : sales@amadish.com / zhan@amadish.com
Web : www.amadish.com / www.parling.com
Copyright(C)2008,Parling Trading Company All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle